C4X-3256
N/A
Report date: 2026/05/22 20:01:29
NME
Base Information
Drug NameC4X-3256
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesC4X Discovery Holdings plc
China Registration ClassN/A
Develop Information
Active CompaniesIndivior Uk LtdIndivior IncIndivior PLC
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A